No coronavirus-related drug shortages yet, says EMA

The European Medicines Agency (EMA) has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

GSK lands 36-country injunction in Pfizer-BioNTech vaccine litigation

12 November 2026 Handing the pharma giant a major win in its feud with Pfizer and BioNTech, the UPC’s injunction reaches well beyond the court’s member states. But with an appeal still possible and parallel disputes playing out across the US and Europe, the fight is far from over.

Pharma

‘No medicine is off limits’: US Chamber of Commerce says stricter import rules may deter fakes

12 November 2026 From GLP-1 drugs to cancer treatments, counterfeiters are exploiting supply chain weaknesses and AI to evade detection. The US chamber’s director of IP tells LSIPR why the fight against fakes is becoming more complex and what lies ahead.

Pharma

Eli Lilly follows Novo in UK High Court bid to block ‘black-market websites’

10 November 2026 The pharma giant has filed a trademark and passing off claim in London to try and prevent UK consumers from accessing fake weight-loss drugs and other prescription medicines, after its rival’s success in a similar claim earlier in 2026.